Latest / Adventures Through The Mind / The State Of The Psychedelic Renaissance | Shelby Hartman ~ ATTMind 211
Transcript
- 0:00Thank you, Portier Supplies, for sponsoring this episode.
- 0:03Portier are the makers of the Portal Box, a beautiful handmade wooden
- 0:09vessel specifically designed to honor the medicine of DMT.
- 0:14Portier also makes the ceremony box, which is specifically tailored to mushroom tea.
- 0:19If you'd like to learn more about the portal and the ceremony box,
- 0:21head to jameswjesso.com forward slash portal box to learn more, and use the
- 0:26promo code ATTM10 to get 10% off
- 0:30your order.
- 0:44TBD, what's going to happen in psychedelics, but I do appreciate
- 0:47that there are a lot of stakeholders who care who are trying
- 0:50to have conversations about this now.
- 0:52How do we bring indigenous stewards to the table?
- 0:55How do we create models that are going to decrease the
- 0:58price of psychedelic medicine?
- 1:00How do we have important conversations
- 1:03about integration and the fact that psychedelics aren't for everybody?
- 1:08Rather than romanticizing psychedelics as the panacea for the quote mental
- 1:12health epidemic that we find ourselves in now.
- 1:15Hello and welcome back to Adventures Through the Mind.
- 1:17My name is James Jesso.
- 1:18I'm your host here as always.
- 1:20This episode is gonna feature an interview with Shelby Hartman.
- 1:23She's a journalist and a co-founder of DoubleBlind, which is one of the
- 1:28premier online and physical print magazines exploring all things pertaining to
- 1:34psychedelic culture.
- 1:35She's also the co-host of the new book, The DoubleBlind Guide to
- 1:39Psychedelics, A Road Map to Tripping, Microdosing, and Beyond,
- 1:43which is visually stunning, beautiful book, you know, properly coffee table book,
- 1:48and incredibly insightful for psychonauts and uh newbies alike.
- 1:53Now, given what Shelby does, she is in this really cool position where she is on the
- 1:59front edge of things transpiring in the so-called psychedelic
- 2:03renaissance as a journalist reporting on all these things.
- 2:06She is tracking, she's paying attention, she's, you know,
- 2:09like I said, reporting on it.
- 2:11Also, as the you know, head of a team of people, she also has many other people that
- 2:16she's working with who are all kind of taking their looks in different
- 2:18directions, building what is effectively the DoubleBlind sort of media milieu.
- 2:23And so because of that, she has a unique view, and a view I
- 2:28wanted to, you know, harvest here for Adventures Through the Mind.
- 2:30I wanted to have her on the show and say, So what's up with the
- 2:33psychedelic renaissance?
- 2:35Like what's actually happening now?
- 2:37Where's it going good?
- 2:38Where's it going poorly?
- 2:39You know, we've got incredible advances in science just exploding everywhere.
- 2:43We've got um presidential executive
- 2:46orders that are fast-tracking psychedelics through, you
- 2:49know, the through the FDA approval process, but we've also got
- 2:53the rise of weird sort of like Charlatan microdosing shaman
- 2:58coaches that are trying to ultimately extract money.
- 3:02We've got an explosion of psychedelic therapies that aren't
- 3:05necessarily being conducted well.
- 3:06We've got the sort of eroding of psychedelic ideals because of corporate
- 3:12influence and all sorts of other things.
- 3:15And then ultimately the question of w where does it seem like this whole
- 3:19psychedelic renaissance thing is going and is it gonna end up really benefiting
- 3:24people the way that we hope it will?
- 3:27That's effectively what we're going to talk about today.
- 3:29As always, timestamps and uh chapters are included in this
- 3:33episode wherever you're checking out, so you can take a look
- 3:35at what's upcoming, or you could just dive in or you can jump to
- 3:38whatever one you're interested in.
- 3:40Either way, there's no more preamble from me here in the intro.
- 3:43Please enjoy this episode with Shelby Hartman on Adventures Through
- 3:47the Mind, episode two hundred and eleven.
- 3:50Shelby Hartman, welcome to Adventures Through the Mind.
- 3:53Thank you for having me.
- 3:56So uh one of the things that has me excited to have you on the show here is that
- 4:03The position you seem to occupy right now in terms of journalism,
- 4:07psychedelic culture with DoubleBlind and your own work is that
- 4:11you have a an excellent sort of I
- 4:14guess like a position for looking at what's transpiring presently.
- 4:20within the so-called psychedelic renaissance and you know knowing
- 4:25your work and the work of DoubleBlind, it's also, you know, contextualized in the
- 4:29history of the psychedelic movement over time and psychedelics
- 4:33beyond our modern movement.
- 4:35So I wanna focus on that today, because I feel very interested
- 4:40in hearing your perspective.
- 4:42Starting with the first question, a stage setting question, which is
- 4:47How would you characterize um the current landscape of the so
- 4:52called psychedelic renaissance.
- 4:55Hmm.
- 4:56Well, I think we have to go back a little bit to understand where we are right now.
- 5:02So most people probably know that the first wave of psychedelic research
- 5:06in the United States happened in the late 50s and early 60s,
- 5:09and then was shut down in the early 70s by Richard Nixon when he
- 5:13signed the Controlled Substances Act.
- 5:16And then in the early 2000s, we had a resurgence of psychedelic research beginning
- 5:21with some clinical trials looking at the promise of psilocybin for depression.
- 5:26and a number of other conditions at Johns Hopkins and NYU universities.
- 5:31And that really began what we're now referring to as the psychedelic renaissance.
- 5:36Now for the first, let's call it
- 5:40Uh Fifteen years or so, um
- 5:47What we mostly saw were universities investigating the therapeutic potential of
- 5:52psychedelics just to understand what they could and couldn't do and their safety
- 5:58profile and all the other sorts of things that people look at when
- 6:01they're investigating the potential of a medicine or a drug.
- 6:05And then we had one primary research organization by the name of MAPS, the
- 6:10Multidisciplinary Association for Psychedelic Studies,
- 6:13that was trying to get MDMA for post-traumatic stress disorder.
- 6:18Through the FDA approval process.
- 6:20We also had some other
- 6:24organizations like the Usona Institute that was looking at
- 6:28psilocybin for depression, but really, for the most part, we had a very
- 6:32small nonprofit landscape that was trying to get these drugs, these medicines,
- 6:37depending on how you understand them, approved by the FDA.
- 6:42And then all of a sudden, you know,
- 6:45about 10 ish years,10 years.
- 6:47Ten, 15 years ago, we had for-profit pharmaceutical companies that looked a lot like
- 6:53the for-profit pharmaceutical companies that we refer to as big
- 6:57pharma that sort of prioritize profit over benefit, arguably,
- 7:01depending on who you ask, coming into the landscape and
- 7:04investing many, many millions of dollars in getting a whole host of novel
- 7:10psychedelic compounds through the FDA approval process for a whole
- 7:14host of conditions, whether it be eating disorders.
- 7:19I mean, everything under the sun.
- 7:20You have people investigating for various dependencies and addictions.
- 7:26And that really has changed the complete landscape and has led us to where we are
- 7:31now, which is that there is an entire sort of pharmaceutical, psychedelic
- 7:35pharmaceutical industry that some people refer to as corpadelics,
- 7:40that has emerged around getting various types of
- 7:43psychedelics essentially legalized so
- 7:46that they can be prescribed through.
- 7:49a doctor's office in conjunction with therapy.
- 7:52At the same time, we have had a grassroots policy movement that has
- 7:59blossomed really beginning in twenty
- 8:05nineteen when
- 8:09Uh, Denver became the first city in
- 8:12the United States to decriminalize a psychedelic at the local level.
- 8:17It's not true decriminalization, but these bills are referred
- 8:21to as decriminalization.
- 8:23Really, what they're doing is they're telling local law enforcement to deprioritize
- 8:29arresting people for the possession, growing, and gifting of naturally occurring
- 8:34psychedelics.
- 8:36So Denver passed a bill that decriminalized.
- 8:40I'm putting that in quotes, made it a low law enforcement priority
- 8:43psilocybin, and about a month later, Oakland City Council followed by
- 8:48decriminalizing all naturally occurring psychedelics.
- 8:51So anything that comes out of the ground that was formerly criminalized,
- 8:55that included, you know, mushrooms, but also ayahuasca,
- 9:00peyote, um
- 9:03I mean there's a lot of there's a lot of naturally occurring psychedelics.
- 9:07Um and since then we've had
- 9:10Dozens of cities and counties that have decriminalized psychedelics at the local
- 9:15level.
- 9:17So I would say that when we look at the psychedelic movement today,
- 9:21there's different threads that are progressing kind of simultaneously, and different
- 9:26stakeholders that are invested in those threads, but two of the major ones are
- 9:30the decriminalization efforts at the local level and also the efforts to
- 9:34get psychedelics legalized through the FDA.
- 9:38There's a few other threads I could point.
- 9:39pull out including like psychedelic churches, for example, that are trying to get
- 9:44exemptions from the DEA to offer psychedelics as a sacrament.
- 9:49We also have state legal initiatives such as Oregon and
- 9:53Colorado, which have legalized psychedelics for um therapy
- 9:58at the state level.
- 10:00Um, but there th those are kind of the main, you know, the main
- 10:05ways that that we see psychedelics
- 10:09being reformed right now in the United States and beyond.
- 10:13Hm. I'm wondering if you could also comment on um the kind of with the
- 10:19With the reality being that psychedelics outside of very specific pockets, uh being
- 10:25ultimately still federally illegal,
- 10:29very illegal, the there uh being a growing
- 10:34sort of marketplace for drugs being sold online.
- 10:39Um like that kind of that movement of selling psychedelics
- 10:43online and additionally the movement of popularity in psychedelics, allowing for
- 10:48people who are attempting to properly profit, either financially or socially,
- 10:54on positioning themselves as psychedelic people or psychedelic
- 10:59coaches or psychedelic entrepreneurial
- 11:02specialists.
- 11:04peak performance with psychedelics.
- 11:06But th those are two other uh sort of like threads that I I'm wondering if you
- 11:09could comment on a bit.
- 11:11Yeah, so the first one is essentially
- 11:16Um, what a lot of people are referring to as gray market
- 11:21recreational sales of psychedelic products.
- 11:25And I always think it's really important to let people know that it is not
- 11:31legal to sell psychedelics for recreational purposes anywhere.
- 11:37in the United States right now.
- 11:39So if you go to a website
- 11:42or a bodega in New York or a dispensary in the Venice
- 11:48boardwalk and they're selling you mushroom chocolates and they tell you
- 11:51that, oh, it's gray market because we've decriminalized, which by the way, LA hasn't
- 11:56decriminalized, you know, it's not true.
- 11:59It's just it's illegal what people are doing.
- 12:02And um essentially
- 12:06Uh what has happened is that because so many um
- 12:12Cities have now decriminalized psychedelics and made them a low law enforcement
- 12:17priority.
- 12:19it feels as though there's been
- 12:22just sort of a shift in the mentality around psychedelics and in how
- 12:31Willing.
- 12:33so called entrepreneurs are
- 12:39To be
- 12:42You know, Essentially doing things that they probably shouldn't be
- 12:47doing right now, right?
- 12:48I mean, you look at uh I I think a lot of these entrepreneurs are really
- 12:54You know, trying to look back at history and look at what happened with cannabis.
- 13:00And when you look at what happened with cannabis, you know, a lot of the people
- 13:04that sort of got in early, uh, before recreational sales
- 13:09were uh permitted, for example, in California, um, ended up making
- 13:14a lot of money in those early days.
- 13:16And they also ended up being trailblazers in a big way, in terms of helping
- 13:21destigmatize the um.
- 13:25You know, medicinal benefits of the plant.
- 13:28And ultimately, sadly, a lot of those people, you know,
- 13:32like all the growers up in Humboldt County and stuff, ended up not being
- 13:36able to, you know, actually compete in the legal market, which is a
- 13:40separate conversation.
- 13:41But a lot of those folks, you know, in the early days were monetarily rewarded and
- 13:47also served as sort of like cultural trailblazers for policy reform, right?
- 13:52So I think a lot of folks who are kind of doing The same thing in in with shrooms
- 13:57primarily, but also other psychedelics see themselves that way.
- 14:00Um I mean, there is a big opportunity right now, potentially, to make money, right?
- 14:06Because a lot of folks are becoming curious about, you know,
- 14:10psychedelics and they don't really know where to go to access them.
- 14:14But, you know, another sort of uh
- 14:18Piece of education that I feel like it's important to provide to people is
- 14:23that just because something says that
- 14:27it has shrooms in it does not mean it has shrooms in it.
- 14:30And DoubleBlind actually was
- 14:33one of DoubleBlind's contributors, webright was the recipient of the UC Berkeley
- 14:38Tim Ferris reporting grant.
- 14:40And so what we did with him is he went out to a variety of
- 14:46bodegas, primarily in New York, but brick and mortars and bought uh products
- 14:51that said that they had shrooms in them and we sent them all
- 14:54to an independent lab to have them test it and almost none of them
- 14:58actually had psilocybin in them.
- 15:00Um they had all kinds of stuff in them.
- 15:02Some of them had really high levels of THC, some of them
- 15:05had muscimol, which is the um
- 15:08Psychoactive ingredient in the Amanita muscaria mushroom, which does
- 15:14actually sit in more of a legal gray area, but feels nothing like
- 15:18psilocybin if you take it at high doses.
- 15:21So it's really, really important, you know, as always, to know your the the source
- 15:27of your medicine.
- 15:30But especially in these times where, you know, there's a wide level
- 15:33of integrity in terms of why people are selling these products.
- 15:37Some people really care.
- 15:39and want to help and want to make the medicine accessible and other people
- 15:42are just trying to make a buck.
- 15:43So that's the first thing I would say about that the the psychedelic products.
- 15:47It's really the wild, wild west out there right now with that.
- 15:51Um and then the second question was second part was about what?
- 15:55Can't remember.
- 15:56It had to do with um you know people
- 16:00People positioning themselves.
- 16:03Right as like shamans and facilitators and that whole thing.
- 16:06Well, that's a thing, but yeah, also coaches and and wellness.
- 16:13Yeah, yeah, yeah, yeah, yeah.
- 16:14Same okay, same same thing.
- 16:16So so I would just say across the whole industry, whether you are looking at
- 16:22sitting in a ceremony, whether you're looking at working with
- 16:26an a facilitator, whether you're buying a psychedelic product,
- 16:30whether you're Whether you're looking at working with a psychedelic coach,
- 16:32like whatever it is, know that um you have you have to vet
- 16:37the things you're buying, the people you're working with, especially when it
- 16:41comes to something as
- 16:45potentially profound, but also harmful as a psychedelic experience.
- 16:50Um and so there's just a wide level of of integrity w wid
- 16:54wid widely varying levels of integrity when it comes to all of these things.
- 16:59Um The coaching industry is very interesting to me.
- 17:05We've been wanting to report a feature on this in DoubleBlind for a while.
- 17:10And you know, what's going on in the coaching coaching quotes industry way extends
- 17:16beyond what is happening with psychedelic coaches specifically.
- 17:19I mean, as we know, the problem with coaches is anyone can
- 17:23decide to call themselves a coach, and you know, who says who?
- 17:27Where were you trained?
- 17:29Who were your teachers?
- 17:30What is yourIs your framework?
- 17:32What are the results gonna be?
- 17:33Where are your testimonials?
- 17:35Are they real?
- 17:36You know, so um You know, there are a lot of people out there right now who are um
- 17:45You know, branding themselves as microdosing coach, you know,
- 17:49micro dosing experts and coaches, or life coaches, or wellness coaches,
- 17:56or anything you want to be coached on, you can find it
- 17:59on Instagram, but that doesn't mean you should pay for it.
- 18:02Um, and you know, similar, similar uh thing happening with, you know,
- 18:08facilitators, shamans, space holders, anyone who's actually holding
- 18:12space for folks on large doses of psych.
- 18:15Good Alex.
- 18:17Hmm.
- 18:18So you you've mentioned a couple of things that are you know of of
- 18:21warranted concern for people.
- 18:23You know, the oh well, you know, if you walk into a shop and
- 18:26they're like, here's these like quasi-legal mushroom chocolates,
- 18:29A, they're probably not quasi-legal unless B, they don't actually
- 18:32have any mushrooms in them.
- 18:33Uh so there's there's that, and then the questionable
- 18:37integrity of uh any individual.
- 18:39Of course, questionable means that they could have really good,
- 18:42high, incredible integrity.
- 18:43They could be an excellent coach, well worth your money,
- 18:45same as a shaman of facilitator, but it could also be the The exact opposite.
- 18:50Um and in that respect we've got these sort of layers of concern
- 18:53with certain aspects of the of the Renaissance.
- 18:57But looking back on um no, let's see, how's my how's my memory on this?
- 19:01Looking back on the say the academic track uh and the um sort of
- 19:06corpadelic track and the decriminalization track, um is there
- 19:12anything in the midst of of any or all of these tracks that you
- 19:15see transpiring that give you
- 19:18concern.
- 19:19Well start with concern and then I'll ask you about things that you feel are that
- 19:23you've seen transpiring or see or do see transpiring that you're excited about.
- 19:27But starting with concerns, do you see any particular
- 19:29concerns that m that either are or might not be immediately
- 19:33evident to people who are just kind of quasi paying attention?
- 19:39Yeah, I mean there's always concerns.
- 19:41Um with any type of reform or change
- 19:48On the decriminalization side, I would say generally, um, I
- 19:54am in favor of decriminalization and
- 19:58Almost everyone I know.
- 20:00Oh, in the psychedelic space is because decriminalization just
- 20:03literally means you can't be arrested.
- 20:06You know, you can't have something on your record that's gonna harm your,
- 20:11you know, possibilities of employment and other basic
- 20:14things that you need to survive in this society, uh, moving forward.
- 20:19So I'm personally in favor of the decriminalization of all drugs.
- 20:23I don't think anybody should be incarcerated for the possession or use of drugs.
- 20:27I think we have lots of data showing that that doesn't help anybody.
- 20:33Not the person using the drug and not anybody else who's around
- 20:36the person using the drug.
- 20:38Um In terms of the um
- 20:45the corpadelic track, I would say one of the primary
- 20:50concerns i well, there's a lot of ethical concerns with this.
- 20:55One concern is what we refer to as biopiracy, and essentially
- 21:01what this means is um that
- 21:05you know, a lot of these medicines are taken from
- 21:10indigenous communities and
- 21:14the knowledge around them is taken from indigenous communities that are
- 21:20actually still to this day struggling to just
- 21:26hold on to their territories, like their physical land that they have been
- 21:32stewarding for many generations.
- 21:35Um, and, you know, of course, the West has a long brutal history
- 21:41of colonization and extraction.
- 21:44Um, but particularly when we're talking about plants and fungi that are
- 21:50sacred, and we're talking about um a community of people who
- 21:56like to tout themselves as sort of enlightened and like to tout the value of unitive
- 22:04consciousness, which is this idea that we are all connected and we have a
- 22:07responsibility to other human beings and to all life, really.
- 22:13Um, it's it's um You know, it's hypocritical.
- 22:17And we uh, you know,
- 22:21uh there are some people doing um really amazing work.
- 22:25For example, uh the Indigenous Medicine Conservation Fund, um, the
- 22:30Indigenous Reciprocity Initiative, which is a project that comes out of
- 22:36Chacruna, which is a longtime nonprofit doing good work,
- 22:40uplifting indigenous voices in the psychedelic space.
- 22:43But um, for the most part,We do not see uh large psychedelic
- 22:49pharmaceutical companies actively baking reciprocity into their
- 22:57drug development plans.
- 22:59We see them making synthetic versions
- 23:02of psychedelic plants and fungi that were extracted from indigenous
- 23:07territories and raising many, many millions of dollars to take
- 23:10those compounds to market in a for-profit context.
- 23:15That includes patents and, you know, other types of sort of
- 23:21proprietary strategies that uh essentially are in place
- 23:26to prioritize profit over benefit and to make sure that the investors who took a
- 23:32risk on these companies in the beginning get see a return on their investment.
- 23:37So that's a big concern.
- 23:40It's especially um
- 23:43Um acute right now in regards to debates around ibogaine, because ibogaine
- 23:52is a compound that's originally derived from the Eboga
- 23:56plant, which comes from central and West Africa and has been
- 24:00stewarded by the Bwiti people.
- 24:03And there is a history of uh
- 24:06poachers essentially going into you know the jungles there
- 24:10and poaching iboga, and it takes a long time for that tree to grow.
- 24:15And, you know, some people might argue, well, what does it matter if uh, you know,
- 24:20the ivy gain that's being put through the FTA is synthetic and,
- 24:24you know, kind of sustainable in perpetuity, uh, in its
- 24:27synthetic form, but that's not the point because it comes
- 24:30from the knowledge of these people's, right?
- 24:34And they deserve to be compensated.
- 24:38and considered for that knowledge.
- 24:41So that's one concern.
- 24:43Another concern, and you can cut me off at any point if I'm talking too much.
- 24:48But these are very but these are very complicated questions that you're asking.
- 24:51So there's a lot to say.
- 24:53A second part is
- 24:56Um prioritizing access to psychedelic medicines for
- 25:05all the people who need them in context that make them feel safe and supported.
- 25:11And so as you know, we have seen historically that um
- 25:18You know, the people who most need access to medicine don't have it.
- 25:22And we know that marginalized
- 25:26communities in the United States, whether it is people of color or
- 25:31queer folks or women, oftentimes do
- 25:34not have access to the medicine that they need.
- 25:38And we do not know yet
- 25:41what is going to happen with psychedelics once they actually make it all the way
- 25:47through the FDA process.
- 25:48approval process because we have yet to see a psychedelic make it all the
- 25:51way through the FDA approval process.
- 25:53We thought MDMA was gonna make it through um You know, I mean it was supposed
- 25:58to be legalized, you know, Rick Doblin's been saying for
- 26:01the last ten years it's gonna be legalized next year.
- 26:03So we'll see how long it actually takes.
- 26:06But the point being, once it gets to market, there's a lot of questions around,
- 26:10well, who's gonna qualify, firstly, because the psychedelic will be
- 26:14approved for a particular indication.
- 26:16So if it's approved for, for example, MDMA for post-traumatic stress disorder,
- 26:22then someone in theory is going to need a diagnosis of post-traumatic
- 26:27stress disorder in order to be able to get access to this medicine and have
- 26:30it approved by their insurance.
- 26:32We don't know what that process is going to look like.
- 26:34And if they have another condition that MDMA has shown promise for,
- 26:39because psychedelics have, as I mentioned early on in the
- 26:42conversation, shown promise for a whole host of conditions and diagnoses.
- 26:47Well, are they gonna be able to access it through an uh th th through a
- 26:50mechanism that doctors refer to as off label. Off label means MDMA was approved for
- 26:55post-traumatic stress disorder, but I'm gonna s prescribe it to you for
- 27:01postpartum depression, right?
- 27:03Again, I'm not saying MDMA has shown promise for postpartum depression.
- 27:07I it actually hasn't, as far as I'm aware.
- 27:09I'm just giving an example.
- 27:12And so there are gonna be a lot, a lot of people who could benefit potentially from
- 27:16psychedelics who may not get it covered by their insurance,
- 27:21won't be able to afford it.
- 27:22We don't know how these treatments are going to be priced
- 27:25specifically in the first like years after approval, because generally the company
- 27:32that has patented and gotten the psychedelic all the way through
- 27:35the approval process is going to have some period.
- 27:37of exclusivity on that drug before it's eligible for becoming
- 27:41a uh what do they call that?
- 27:44generic.
- 27:45Right.
- 27:46Right. And this is theoretically to help hel help them recoup the whatever
- 27:49billion dollars it took to get it through the approval process or something.
- 27:53And then on top of all that, you know, there's also this question of um
- 27:58Excessibility from a contextual standpoint.
- 28:03So not everybody w is going
- 28:06to want to do a psychedelic in a clinical context on a
- 28:11couch with a blindfold and two therapists next to them in an office.
- 28:16Some people actually might be better supported doing psychedelics,
- 28:20for example, in a ceremonial context with an indigenous
- 28:23facilitator, in a group setting, in nature.
- 28:28There's a whole question around, you know, who is your therapist going to be?
- 28:33There's been some preliminary research done that has found that, you know.
- 28:40Most people of color do not want to have a psychedelic
- 28:43experience with someone who has no understanding of their
- 28:48cultural background and their upbringing, or a lot of them, right?
- 28:52There needs to be more queer therapists.
- 28:55There needs to be more therapists of color getting trained so that people
- 28:58actually feel like they're they can fully surrender into the psychedelic
- 29:03experience because they feel safe and supported and seen by someone who
- 29:06can relate to them and what they've been through.
- 29:09So there's many, many, many, many layers here to this.
- 29:12And you know, is it is psychedelic
- 29:17p pharmaceutical development a good thing at all?
- 29:20I'm not gonna make a declaration about that right now, one way or the other.
- 29:24It's very complicated.
- 29:25There are a lot of people who will never necessarily try a psychedelic if it wasn't
- 29:31approved by their doctor and it wasn't being offered in a clinical setting.
- 29:35Right. And also there are these, you know, there are challenges as well, as I ref
- 29:41ref referenced before to um trying to offer psychedelics in a less regulated
- 29:46context where you don't know if you're getting what you signed up to get.
- 29:50You don't know what the training is if you're facilitator.
- 29:52So there are benefits to a regulated model.
- 29:56But there's also limitations and potential harms.
- 30:00Hm. Yeah, I'm appreciating you speaking to just how complex such a situation is.
- 30:05I mean even to reference back to your discussion on um access,
- 30:10just access alone, when you're talking about uh from what I
- 30:14understand, when you're when you're talking about like, well,
- 30:16who gets access and what can it be prescribed for and how
- 30:20and if insurance will be funded and how much will it cost.
- 30:24These are questions to protect.
- 30:26directly pertaining to psychedelics, but uh there those problems
- 30:30aren't rooted in how psychedelics are being legislated.
- 30:33They're rooted in how the entire healthcare system is set up.
- 30:37And I can't imagine that the only question is, well, will poor people
- 30:41get access to psychedelics?
- 30:42Well, I think actually th the the there's a huge question of like,
- 30:45well, who is getting access to any medicine and how what's
- 30:48its affordability and its efficacy and and the safety and in the
- 30:52context from which they receive it.
- 30:54So just by you know, bringing up psychedelics or kind of evoking,
- 30:58from what I understand, a a much larger question of how society in many
- 31:01ways is set up to provide people the things that they need
- 31:05through a regulated context.
- 31:07Correct.
- 31:08So what about the uh academic?
- 31:11Brac research side of things.
- 31:12Do you have any concerns for what's going on there?
- 31:16No.
- 31:17Not particularly.
- 31:20I think research is good.
- 31:21I think we live in a culture where unfortunately we um we
- 31:27we still are very attached to this hierarchy of wisdom or knowledge systems we've
- 31:33created whereby we say, you know, certain types of data and information
- 31:37is more legitimate than other types of of data and information.
- 31:41Right. So a clinical trial, a double blind randomized clinical
- 31:45trial is always gonna be seen as far more.
- 31:50Um Powerful.
- 31:53And relevant.
- 31:55to the folks that are in positions
- 31:58of power to change policy, than thousands of years of indigenous
- 32:05um relationship.
- 32:07with what they understand to be animate beings.
- 32:11with their own wills, not just compounds that we take for our own benefit.
- 32:16Um, but you know, right now it's pretty an interest, it's a pretty interesting
- 32:22moment um politically for psychedelics
- 32:25because we're obviously in a time where there's a lot of political polarization,
- 32:30and yet psychedelics are one of the few issues that are pretty bipartisan.
- 32:35You have a lot of folks on both sides of the aisle that are
- 32:38advocating for psychedelic reform.
- 32:41Um, a lot of Republicans are advocating for it because of the
- 32:44promise that it's shown to treat.
- 32:46Veterans because the VA has been failing many veterans who have come
- 32:50back from you know combat with PTSD and a whole host of other
- 32:54conditions, and what we have available is not working for a lot of them.
- 32:58Um so this is to say that
- 33:02um research is important because all those people want research.
- 33:06The Democrats want research, the Republicans want research, everybody wants it.
- 33:12Trump wants research, he just signed an executive order to put you.
- 33:16You know, ten million dollars towards psychedelic research.
- 33:19Joe Rogan wants research.
- 33:20Everybody wants research.
- 33:23Mm-hmm.
- 33:25And I yeah, I agree.
- 33:26And I'm I'm actually I would say I'm more on the animist camp of
- 33:29things, although I I do think that it's important that, you know.
- 33:33that uh we do have a hierarchy in
- 33:36terms of what type of data we consider to be, you know, more objectively robust.
- 33:42Um, because I think I think it's fair that if you have a hundred people saying,
- 33:47this thing really worked for me, but you have a double blind placebo
- 33:50controlled study that says we show absolutely no evidence
- 33:53that it really worked for any of them outside of it being placebo,
- 33:57and all that does is remind us that placebo is amazing and we should be trying
- 34:00to optimize that.
- 34:01It doesn't say that we should We should fully regulate this and
- 34:04have doctors giving out uh this drug or this medicine
- 34:09or or what have you.
- 34:10Um so I'm I'm I am personally like all for the hierarchy of
- 34:15robustness that data is uh s sort of acknowledged as as having.
- 34:20Well also simultaneously, from what I understand,
- 34:22perhaps the double blind uh placebo controlled randomized controlled
- 34:28trial is not the best research design for psychedelics to.
- 34:33understand how and why they uh offer what they do,
- 34:36especially in terms of micro dosing.
- 34:38Um so maybe there's a question there.
- 34:41All of science needs to figure out a new way to get robust data on that.
- 34:45Cause yeah, I think that's I guess a side comment that I have about uh the
- 34:51how the research is developing, because I think if we don't
- 34:54figure that out on a scientific end, we might miss out
- 34:56on showing some really good efficacy with psychedelics and instead
- 35:00get these confused things of being like, well, it's not so much
- 35:03It's not really any better psilocybin's not any better
- 35:06for depression than escitalopram based on the way that we did these metrics.
- 35:10And so why bother legalizing psychedelics?
- 35:12We could just give people Prozac when the there might be a
- 35:15whole other host of reasons that we weren't even able to
- 35:18see because of the way that the study was designed limited our
- 35:21capacity to view where those benefits are really taking place.
- 35:24Yeah.
- 35:26Yeah, I mean, it's another really, really big uh systemic issue.
- 35:31Michael Pollan talks about that actually in his most recent book on consciousness.
- 35:35He talks about, you know, do we need to Essentially uh
- 35:43pioneer an entirely new way of investigating.
- 35:47You know, is it time to throw out the scientific method as we know it?
- 35:51Because it's missing a lot.
- 35:55But so long as this is the the format that you know, politicians and
- 36:02funders and you know, everyone else with power in our culture wants to see,
- 36:07we gotta keep doing it.
- 36:11And you know, in fairness, I from what I understand,
- 36:14humans do have a really great track record uh in terms of um letting
- 36:20subjectivity manipulate what did they perceive and how they uh
- 36:24narrativise and characterize what they perceive and have it
- 36:28inclined towards their biases and desires, consciousness,
- 36:32consciousness and otherwise.
- 36:33So much so that even the scientific method meant to to protect from that happening
- 36:42still gets muddied by those same things with you know uh
- 36:46data fudging and what gets funded and why it gets funded and
- 36:50who's on the review boards and what papers make it into what journals
- 36:54based on, you know, like you know, this, this this, and this.
- 36:57Uh so I I do think we need to, again, I think we need to maintain a a certain like
- 37:02rigor in our research, in our data,
- 37:05and what is considered robust and what is considered worth making decisions on.
- 37:10And, you know, like Michael Pollen suggested, there definitely needs to
- 37:13be some deep renovations in what can be included in those assessments.
- 37:18Um, but I'm not one to burn it all down.
- 37:20Uh Uh and to build it anew, unless it burns itself down,
- 37:25in which case, let's harvest what we can uh and build a better world.
- 37:30Um speaking of which, what do you see going well?
- 37:33Uh, you know, more research is good research, I I believe you said,
- 37:37but in terms of uh how things are progressing out there in the
- 37:41in the complex scenario that is psychedelics and legislation and et cetera,
- 37:46where do you see things going?
- 37:48Well Mm-hmm.
- 37:57Well
- 38:01You know, it really depends on
- 38:04Who you're asking?
- 38:06Where you are.
- 38:08what you think is important because obviously psychedelics are my world
- 38:13and I talk about them all the time with people who have tripped,
- 38:16you know, identified as psychonauts and trip more than a dozen times.
- 38:19And um, and then I go to, you know, New Orleans, where I lived
- 38:24for seven years and I talk to people about this and they've
- 38:27never you know, they're like, what are you what are you talking about?
- 38:30What are mu mushrooms, LSD, what is that?
- 38:33Some of these a lot of people still have no idea
- 38:37what's going on within the psychedelic realm.
- 38:40And it could be a very long time before we see a significant
- 38:45number of people actually engaging with these with these plants
- 38:48and and sort of awakening to um their
- 38:52potential.
- 38:54Um So I think there's still some questions about, you know,
- 38:59how long is it gonna take for psychedelics to really proliferate into the culture
- 39:03in a meaningful way, but it is happening more and more.
- 39:07Um I mean I think
- 39:16You know, I wanna say that the the Republican interest in psychedelics is
- 39:23a good thing and that the executive order with I begin is a good thing.
- 39:28Because it's gotten psychedelics so much more attention.
- 39:33But I just don't know.
- 39:35I don't know what's gonna happen with that.
- 39:37I don't know what my position is yet on, you know
- 39:43people doing I begin in a clinical context.
- 39:47A lot of people have been getting harmed that way in the underground.
- 39:54And do you think people would be l less harmed, uh if they were out of
- 39:57a clinical context?
- 39:58'Cause from what I understand.
- 40:00Like if it wasn't for best practices published uh, you know, a little
- 40:03while ago, which significantly decreased mortality, you know,
- 40:07like some level of clinical context is probably warranted for people with Ivy.
- 40:11Oh no, no. Oh no, absolutely, absolutely.
- 40:13People should not be doing Ibogaine outside of a clinical context
- 40:16unless they're doing iboga in a ceremonial context with stewards who really
- 40:20understand the medicine.
- 40:21Sure, and even then except that you might die.
- 40:23It's just to say that I think a lot of people look at the conversations
- 40:30around psychedelics.
- 40:32uh growing in Washington as a positive thing, even if they
- 40:36don't necessarily, you know, align with Maha and Trump and Joe
- 40:40Rogan and that whole thing, although a lot of psychonauts do,
- 40:43actually, um, you know, they see the momentum uh
- 40:49the sort of like political momentum as a positive thing and they
- 40:53see the legalization of these medicines as a positive thing.
- 40:57And like I said, I just I don't know where I stand on that.
- 41:00I think it's too soon.
- 41:02You know, I don't know that everybody sh should be doing psychedelics.
- 41:06I don't know that you know, everybody, you know, that the best context for
- 41:11them to be I mean, you know, the the letter that was
- 41:13put out recently by the Indigenous Medicine Conservation Fund is
- 41:17they are not these the stewards of these medicines are not supportive.
- 41:21of the executive order and of this type of reform.
- 41:28One thing I would say that I do think is positive is I think
- 41:31that the growing conversations around the intersection of psychedelics and systems
- 41:38change and equity and indigenous reciprocity and stewardship,
- 41:42all of that to me is very positive.
- 41:44Now it's still pretty fringe.
- 41:46Again, it's not like, you know, it's not on the radars,
- 41:48or it certainly isn't a priority at all of, you know, the
- 41:52people that are working on this on the federal level, or many of the
- 41:56pharmaceutical companies that are.
- 41:58Trying to legalize these drugs, but you do see more and more and more people on the
- 42:02grassroots level, as well as psychonauts becoming interested in these conversations.
- 42:06And I think that right now, you know, we're in a really crucial uh moment,
- 42:12sort of a choice time for psychedelics in terms of how they're going to be
- 42:16framed and how they're going to be understood.
- 42:18I mean, a lot of people look at what happened in cannabis and they don't
- 42:22want to see a repeat of that in psychedelics.
- 42:25What happened in cannabis being just to recap.
- 42:28happen sort of what I referenced before, a lot of the folks that
- 42:31really uh gave their whole lives to growing this plant and destigmatizing it and
- 42:38making it accessible to people that really needed it.
- 42:41Cancer patients that were going through chemo, that had nausea and
- 42:44needed it for that, and children with epilepsy who are having seizures,
- 42:48and veterans with insomnia who were having nightmares and they
- 42:52they worked under the radar quietly for many decades to get
- 42:55this medicine available and then When proposition sixty four was
- 42:59passed in California, they literally could not compete and they were
- 43:03completely shut out of the market.
- 43:05And now that whole county is just decimated by what has happened with the regulated
- 43:11cannabis market.
- 43:12And so You know, I do appreciate TVD what's going to happen in psychedelics,
- 43:18but I do appreciate that there are a lot of stakeholders who care who are trying
- 43:21to have conversations about this now.
- 43:24How do we bring indigenous stewards to the table?
- 43:27How do we create models that are going to decrease the
- 43:29price of psychedelic medicine?
- 43:31How do we have important conversations
- 43:34about integration and the fact that psychedelics aren't for everybody?
- 43:39Rather than romanticizing psychedelics as a panacea for the quote mental
- 43:44health epidemic that we find ourselves in now.
- 43:46I think the conversations are a good thing.
- 43:49But I can't say specifically that anything that's happening Is gonna be good or bad,
- 43:55'cause we just don't know yet.
- 43:58Known in hindsight, I suppose.
- 44:00I I used to love the set phrase uh h h hindsight's always twenty twenty,
- 44:04but then the events of twenty twenty transpired and it
- 44:07just feels weird to evoke those two uh that number together.
- 44:11Um This episode was sponsored by Portier Supplies, the makers of the Portal Box.
- 44:18The Portal Box is not just a box, it's a proper vessel.
- 44:23It is handmade and built specifically to honor the DMT experience.
- 44:27Portier won the Psychedelic Design Awards last year, and the Portal Box is Y.
- 44:32I personally own one and can tell you they are absolutely beautiful
- 44:36and an incredible way to.
- 44:39honor your medicine.
- 44:40They've also got a ceremony box which is specifically designed for mushroom tea.
- 44:45If you'd like to check out one of the boxes you can head to jameswjesso.com slash
- 44:49portal box and use the promo code ATTM10 to get 10% off your order if you decide
- 44:55you'd like to buy one.
- 44:58So yeah, I'm thinking about the cannabis thing, you know, and and it's complex.
- 45:01I had a friend of mine up in here in Canada situation with cannabis
- 45:05is very different down in the US.
- 45:06Like we are a uh federally legalized for recreational use.
- 45:11There's a model for um accessing
- 45:15medical specific medical use. How it's set up is pretty complicated
- 45:20and doesn't always serve uh patients in particular, uh or small growers.
- 45:26I had a fr colleague, friend of mine.
- 45:28mine who was doing a small grow up uh and it was totally legal uh enough at the
- 45:33time that the police left him alone they knew what was going on because
- 45:37he was working his way up to uh to to basically becoming a licensed
- 45:42producer once the legalization was implemented because everyone knew it was
- 45:45coming down the pipeline it just hadn't happened yet.
- 45:48And uh when it came down to it, the I believe it was something
- 45:52like they needed to prepay one or two hundred thousand dollars
- 45:55worth of taxes for future.
- 45:58for sales in their first year.
- 46:00And they not only needed to have that money up front, but none of it came
- 46:05back to them if they didn't sell enough product to warrant
- 46:09paying$200,$100,000,$200,000 in taxes,
- 46:13which means it was a high likelihood of just losing many,
- 46:18many, many thousands of dollars, which they didn't have.
- 46:21And so police came in and said, I'm sorry we have to confiscate
- 46:23everything now because you were not approved when we came through with
- 46:27only a very few Select people.
- 46:29Uh you know, companies and organizations with heaps of money were able to go.
- 46:33And I live in a society where
- 46:37I can walk in.
- 46:39on in any major city, even small little townships that you wouldn't think
- 46:45are places that you could go buy nice cannabis.
- 46:47And I can walk in and I can buy cannabis and everything is laid
- 46:51out in front of me exactly what's in it and it's all tested
- 46:53and there's problems there.
- 46:55And I can walk out with my joint and I can smoke it walking down
- 46:58the street and wave hello to a police officer, wish them a
- 47:01lovely day while I hit my joint and um there's obviously certain
- 47:06regulations there.
- 47:07You can't smoke weed or you can't smoke cigarettes.
- 47:09That's and that includes, you know, children's play parks and stuff
- 47:12like that, which is fair.
- 47:13But uh yeah, there's a question of like oh it looked like it was
- 47:15all gonna go bad and in in practice it's not great, but still means
- 47:19that people have access to cannabis and they're not persecuted for it.
- 47:23Um so in that way
- 47:26You know, the the process of cannabis in Canada does speak to some positive social
- 47:31changes that can come out of things, even if some things got lost behind.
- 47:34And there's still a flourishing gray market here for cannabis that is not through
- 47:39the regulated market and nobody seems to be doing anything about it.
- 47:42So we'll see how that goes.
- 47:45Um did you want to comment on that before I move on to the next series of questions?
- 47:52Think so.
- 47:55No.
- 47:56Mm-hmm.
- 47:57And you know, I share many of the concerns you've spoken to here, uh,
- 48:00with regards to psychedelics as well.
- 48:02Um, sometimes I have to do some like I almost have to lean into the
- 48:06the learnings, the lessons I've been given with psychedelics to
- 48:10to remember to bring back in this sort of trust and faith and like like
- 48:15like recognize there are positive things that are transpiring
- 48:18because oftentimes the current context of the world, psychedelics and
- 48:22otherwise inclines me to really only see where things are going
- 48:25wrong because a lot of things at this point seem to be going not so great.
- 48:30Um so I yeah, I share I share a number of your your concerns um So moving on.
- 48:38Wanna change trajectories a bit because earlier you mentioned
- 48:41something about, you know, like the media landscape of
- 48:43psychedelics is changing where people are there's more interest
- 48:47in psychedelics generally and in in populations that wouldn't normally be
- 48:51there, and you know, that it's happening in tandem with a a change in
- 48:55how psychedelics are being represented, um, and how often they're being
- 49:00represented in news media and media in general.
- 49:05You run what I I think is sort of a a central crux of some of the most reliable um
- 49:10and and trustworthy content in the psychedelic media landscape,
- 49:15which is DoubleBlind.
- 49:16And um I guess this is a two part question, which is what
- 49:20was the media landscape around psychedelics?
- 49:24Such that you were inspired to start DoubleBlind?
- 49:27Um What impacts have the changes
- 49:33in the media landscape around psychedelics now?
- 49:37Um How has that changed what you hope?
- 49:42DoubleBlind is doing in the midst of all of this.
- 49:44Mm-hmm. Mm-hmm.
- 49:45Yeah.
- 49:46Well Um In some ways psychedelic media
- 49:53coverage has changed a lot and in some ways It hasn't.
- 50:00When we began Uh well, we had the idea at the end of 2018, and we put out our
- 50:05first issue in the June in June of 2019.
- 50:09And at the time, Madison, my co-founder, and I, we were also reporting
- 50:15for Rolling Stone and Vice and other mainstream outlets on psychedelics.
- 50:20And what we were seeing is that there were a handful of stories that
- 50:25were getting a disproportionate amount of coverage, and there was a lot of emphasis
- 50:29on essentially the story.
- 50:31Story of the resurgence of psychedelic research and the psychedelic
- 50:35renaissance and maps and their research looking at MDMA for
- 50:39post traumatic stress disorder.
- 50:40And a lot of that was spurred by Michael Pollen because he wrote
- 50:43his big feature, The Trip Treatment in the New Yorker, which
- 50:46served as the template for How to Change Your Mind, which also focused largely on
- 50:52psychedelics as a tool for individual therapy and well being,
- 50:56rather than as individual indigenous technology or as animate beings for system.
- 51:01systems change which he's since started to talk about more um
- 51:07And uh DoubleBlind just felt like
- 51:11There was uh, you know, there were all kinds of stories that
- 51:15were important that were being missed.
- 51:17And um, that those were stories
- 51:20about uh psychedelic culture and about the people that were
- 51:25preserving the underground and the psychedelic spirit and the psychedelic ethos.
- 51:31Um, Madison said in the early days, and now we say it all the time,
- 51:35we're not trying to make psychedelics mainstream, we're trying to make the
- 51:38mainstream more psychedelic.
- 51:41And so that That means we don't want to see what happened in cannabis, which was
- 51:45essentially a a de st uh uh as a part of the destigmatization campaign,
- 51:49all of a sudden uh, you know, graphic designers and um you know
- 51:56uh UX people and marketers
- 51:59and every type of person from other industries came in and they tried to, you know,
- 52:04s essentially strip out the uh the cultural underpinnings of the plant, right?
- 52:11And um the music and the festival and the joy and the community.
- 52:19And um, you know, can plants be medicine,
- 52:24uh, medicines for specific therapeutic indications and also
- 52:30um catalysts for culture and art making?
- 52:34Of course they can.
- 52:36Of course they can and they have been and they are, right?
- 52:40So that was a big part of it was the preservation of psychedelic
- 52:43Culture and ethos and spirit, and also um all these ethical conversations that we've
- 52:48been talking about around corpadelics, around accessibility, around equity,
- 52:53around indigenous stewardship.
- 52:54And um, since then, we have seen mainstream publications publish some really
- 53:00amazing nuanced stories about all of these topics.
- 53:04Um, the Washington Post did a big feature a few years ago now.
- 53:08I can't remember exactly when, essentially on this question of accessibility and
- 53:14um some of the uh uh efforts that were being made to um um
- 53:19diversify psychedelic therapy
- 53:22world with trainings and research looking at um you know how
- 53:28to make clinical trials and psychedelic therapy more uh sort
- 53:33of safe for people of color.
- 53:35Um, a lot of that work around Monica Williams research and Um
- 53:41Yeah, and we've seen, you know, we've seen all kinds of stories.
- 53:45We've seen stories on um, yeah,
- 53:48the sort of burgeoning psychedelic uh products uh movement.
- 53:53Um, a friend of mine and a contributor to DoubleBlind, Michelle Luc,
- 53:57did a really great feature in the LA Times about um, you know,
- 54:01psilocybin products and different kinds of sort of like parties and events that are
- 54:06happening around some of these sort of quote unquote gr, you know, gray
- 54:10market products.
- 54:12So we've seen a lot more of that popping up.
- 54:14You know, Shayla Love, who was at Vice and now is at The Atlantic,
- 54:18has done a lot of amazing reporting that has made it into some more
- 54:21mainstream publications.
- 54:23And we've also seen a lot of new,
- 54:28not a lot, but a handful of new psychedelic media companies and projects pop up.
- 54:34Many more podcasts, certainly some um print magazines.
- 54:38Doubleblind was the first psychedelic print magazine, really,
- 54:41that I'mI'm aware of certainly in the United States, and now there's a
- 54:44couple others.
- 54:46Um, the Microdose, which is UC Berkeley's uh newsletter that does amazing uh
- 54:51reporting on the psychedelic space, did not exist when we launched.
- 54:55That came out, you know, probably four ish years after
- 54:58DoubleBlind was in existence.
- 55:00So a lot, a lot has changed.
- 55:04Hm. Do you feel like um
- 55:08Do you feel like With the you know, there's some there's some great publications
- 55:13coming out, and there's a lot of I mean, the reality is like
- 55:16there's still some great journalism in the world.
- 55:18There's a lot of churnalism and just adds there.
- 55:25And just like a lot of things that are presented as uh as news,
- 55:29but they're really just uh really long winded ways to get you to
- 55:34scroll to the very bottom of the page to know one thing so that and be served 27
- 55:39ads on the way down.
- 55:40Um so in the in in the midst of
- 55:44just psychedelic journalism in particular and the growing
- 55:47kind of just push of people talking about it at varying degrees of integrity.
- 55:52Do you feel that that Your sense of responsibility as a journalist uh with double
- 55:58blind and you know, reporting on psychedelics has grown.
- 56:02Or do you feel like it's kind of like You know, your mission was the
- 56:06same then as it is now, right?
- 56:07Like working what you say, working to uh s make the mainstream more psychedelic.
- 56:12Or do you feel like you take on greater responsibility now as as the
- 56:16landscape has changed, or you feel it kinda has stayed the same?
- 56:20Well I would say the level of responsibility is the same, but
- 56:29The stakes feel higher.
- 56:31Um, if that makes sense.
- 56:33I mean, when we first launched, as I mentioned, a lot of people were not even having
- 56:38conversations about indigenous reciprocity and stewardship and
- 56:42access and equity and all these other things.
- 56:45Um, there were some people, like Shikruna, for example, has really been holding
- 56:50it down in terms of the conference series and the articles
- 56:52and everything, but they were really appealing to folks that are
- 56:57already working in psychedelics as opposed to, you know,
- 57:00kind of your mainstream psycho.
- 57:01Uh um And so when we launched the responsibility was
- 57:08Or the primary goal was like let's get people to even talk about these things.
- 57:14Right. And now It's still let's get people to talk about these things, 'cause a lot
- 57:21of people aren't, but it's also Let's get them to care and let's get
- 57:26them to understand the importance
- 57:29because there's still a lot of people that are not familiar with
- 57:33these conversations at all.
- 57:35Um, certainly, you know, your mainstream psychonaut.
- 57:38Um, also uh mainstream journalists, like when I'm interviewed as an
- 57:43expert, for example, in the mainstream media, as opposed to
- 57:46reporting for the mainstream media.
- 57:49I'm, you know, I'm never, ever, ever asked a question about indigenous.
- 57:53Reciprocity and stewardship.
- 57:55But at the end, when they say, is there anything else you'd like to mention?
- 57:59I say, yes, thank you so much for these questions about, you know,
- 58:02Trump's ex uh executive order on IBGame and Joe Rogan, and I'd like to mention
- 58:06this thing called biopiracy.
- 58:09And about 15% of the time it makes it into the article.
- 58:13You know? So there's still a lot of people not even talking about these things,
- 58:16but then there are people who are aware of them within the space, I would say.
- 58:21Uh probably most.
- 58:24Venture capitalists and folks that are involved in the corporate Lic
- 58:28sphere know that this is a conversation that's happening.
- 58:33But do they care?
- 58:36Well, Hopefully our coverage will encourage them to reconsider
- 58:41their position if they don't Or if some part of them does,
- 58:45but they have yet to take action.
- 58:49Hm. And I like to this is something I remind myself too.
- 58:52It trif it turns out that the work that I'm doing is not
- 58:57Part of the the linchpin that turns society for the better.
- 59:01At least I did it.
- 59:03Yeah.
- 59:05Right.
- 59:06Yeah, and I I mean for myself, I mean if I put myself on the on the soapbox here, um
- 59:12Yeah, I've been doing this podcast for a little over ten years.
- 59:16I wrote my first book about mushrooms, came out in twenty thirteen.
- 59:20I was teaching about the benefits of developing a living
- 59:24relationship with the with the spirit of the mushroom, with like the mushroom as
- 59:28a being that we interact with at the very least on a
- 59:31subjective level, if not on a deep spiritual level, and the benefits
- 59:34of going through the difficulties and calling it into our
- 59:37lives to become better people.
- 59:38I've been doing this for well over ten years and and the landscape has changed.
- 59:42Change quite a bit.
- 59:44from people initially thinking
- 59:48Sounds like a bunch of bullshit.
- 59:49Sounds like you're just trying to justify your own ability uh your
- 59:52own desire to take drugs to
- 59:55Oh wow.
- 59:57Uh CNN and Fox News and Donald Trump's in the White House
- 1:00:01signing an executive order saying, let's fast track psychedelics for medicine.
- 1:00:06We need to support our veterans.
- 1:00:07Like that's a that's a big that's a big jump.
- 1:00:10And as things have changed for me over time, it has been increasingly um
- 1:00:16Trying not to let all of that detract me from what was the original
- 1:00:21mission in a way, which is like let's have deep and thoughtful conversations about
- 1:00:24psychedelics and not to chase
- 1:00:28chase the next thing or chase the
- 1:00:31the um the next big um
- 1:00:35algorithmic push, like the next thing on the algorithm that's gonna
- 1:00:39get me this or that, like to not let the possible financial and social
- 1:00:43profiteering that can happen from being associated with psychedelics
- 1:00:46to change me f from what I was trying to do, which is like
- 1:00:50And the main thing of this podcast is like how can we work with and through
- 1:00:54psychedelics to become better people, not just for ourselves,
- 1:00:57but for all those with whom we're nesting in relationship with
- 1:01:00presently and across time, human and non-human alike.
- 1:01:03And That is, you know, kind of like biopiracy.
- 1:01:07That's not always the most interesting thing, uh, in terms of the of the news cycle.
- 1:01:12And I And as things change with psychedelics, it's almost like much of
- 1:01:16what I see gets increasingly like I'm not sure I want to be associated with
- 1:01:20that by having psychedelics in my in my in my bio line or something.
- 1:01:23So I've just been working, you know, to to stay consistent with what my
- 1:01:28mission has been since the beginning, in the midst of all these changing
- 1:01:31things, and hopefully contribute to something positive, less in terms of
- 1:01:35uh what you're doing at DoubleBlind, you know, in in what you're reporting
- 1:01:39and maybe more in terms of just inviting people to ask and consider
- 1:01:43these larger reflections.
- 1:01:44As they wonder about their own relationship with psychedelics over time.
- 1:01:47Mm-hmm.
- 1:01:49Yeah.
- 1:01:50I mean that's great.
- 1:01:51And I was just listening to a podcast interview with apprentice Hempel at Francis
- 1:01:57Weller.
- 1:01:57Um Francis Weller.
- 1:02:00Yeah, he's uh one of my favorite authors.
- 1:02:03He wrote a book called The Wild Edge of Sorrow and
- 1:02:06Um, he essentially said, you know,
- 1:02:10he doesn't know where all of this is headed.
- 1:02:13Um, you know, Prentis had asked him about hope.
- 1:02:17hope in these times.
- 1:02:18And he said, Well, you know, whether or not I have hope
- 1:02:22doesn't change my responsibility.
- 1:02:25Yeah. You know, I'm gonna I don't know what's gonna happen.
- 1:02:28But I still have to show up and do the work.
- 1:02:32And I thought that that was profound.
- 1:02:34Yeah, I feel that.
- 1:02:37Um So I got a couple more questions here before we w be before we sort of round out.
- 1:02:44Uh
- 1:02:47For people who are Uh, see, this question almost seems
- 1:02:51like it should have been maybe at the beginning, but if people are
- 1:02:54still listening who are new to the space, uh what do you think um
- 1:03:00What do you think the s s sort of if you look at the broader messaging of the
- 1:03:05psychedelic media landscape
- 1:03:08What do you think people are getting the wrong idea about?
- 1:03:11Mm-hmm.
- 1:03:12Yeah, I mean I sort of referenced this before, but I would say
- 1:03:17we do h s continue to s
- 1:03:21hear a lot of stories oftentimes centered around veterans,
- 1:03:25but all types of people who are suffering and then they go and they have
- 1:03:29some big psychedelic experience and then their life just turns around.
- 1:03:33And I think that's a really um
- 1:03:38I think that's a really irresponsible narrative, to be honest,
- 1:03:44because that's not how psychedelics work for most people.
- 1:03:47And it's probably not even how they're working for a lot of the people
- 1:03:51that are featured in these movies.
- 1:03:53What happens to them a year, two years, five years down the line,
- 1:03:56I'm not saying they didn't receive meaningful amounts of
- 1:03:59healing from the experience, and that healing didn't inspire them to make
- 1:04:02significant changes in their life.
- 1:04:04But what I am saying is that
- 1:04:08It's not that simple.
- 1:04:09Right, for sure.
- 1:04:11And um Generally, when a person cultivates a relationship
- 1:04:17with psychedelics, sometimes people, you know, they have an
- 1:04:20experience or two and they go, Well, that was helpful,
- 1:04:23or that was interesting, or that was not helpful, and then they just
- 1:04:27never do it again, and that's fine, and everyone's on their own path.
- 1:04:30But a lot of people, when they do have this their first psychedelic experience,
- 1:04:36they go home and they integrate it, and then they come back again,
- 1:04:40and then maybe six months later, again and again and again.
- 1:04:43And it becomes sort of a lifelong journey or spiritual practice.
- 1:04:48It's it's a relationship the way meditation is a relationship,
- 1:04:51exercise is a relationship, journaling is a relationship.
- 1:04:54And you have to stick with it and you have to come back to it in its
- 1:04:59right time and you have to take the right dosage and you have to,
- 1:05:02you know, it's it's it's um and I assume right in the in the sort of eightfold noble
- 1:05:08path kind of right, you know, like uh right action, right livelihood, not
- 1:05:12uh Correct.
- 1:05:13No, I appreciate no, I appreciate you clarifying that.
- 1:05:17Um It's
- 1:05:21Yeah. So when I say right, what I'm referring to is
- 1:05:27a thoughtfulness and an intention.
- 1:05:30Right.
- 1:05:31And so maybe like an an alignment with with what best serves that relationship
- 1:05:37and its benefits in your life and beyond you or something to that effect.
- 1:05:40Yeah, sure.
- 1:05:41Just being just being thoughtful.
- 1:05:43So if you feel called to have a psychedelic experience, um, not just,
- 1:05:48you know, buying the first mushroom chocolate bar you see at a bodega and taking it
- 1:05:52by yourself in the forest.
- 1:05:54Like that could work out well for you.
- 1:05:56It's worked out for some people, but it's good to just be thoughtful
- 1:06:00about why do you want to have this experience?
- 1:06:03What are you looking to get out of it?
- 1:06:05What do you need?
- 1:06:06Is it really the right moment in your life?
- 1:06:08These are all things we get into in our book.
- 1:06:10That's why we put the book out, right?
- 1:06:11For the person that's like, I'm ready now.
- 1:06:15'Cause there's a lot to consider and um and it's not going to heal all of your
- 1:06:21problems and, you know every give you everything you ever wanted in your whole life,
- 1:06:26including like happiness and health and and the meaning of of all things.
- 1:06:30That's not what these things do.
- 1:06:32They are tools.
- 1:06:35that you can cultivate a relationship with that can support you the way many,
- 1:06:38many of you Let me let me nudge in here.
- 1:06:40I'm gonna interrupt but you s there are tools, but you also
- 1:06:43have said that we're missing The perspective that they're living beings.
- 1:06:47So are they tools or are they living beings?
- 1:06:50As soon as I use the word tool, I
- 1:06:54I I realized that maybe that implied that they are commodities or something to be
- 1:07:01objectified and taken for our own benefit.
- 1:07:03But what I mean by the word tool is it can support you, among other things.
- 1:07:09It's not the thing.
- 1:07:11Mm-hmm.
- 1:07:12The end all be all thing.
- 1:07:16Um
- 1:07:20So that's what I would say.
- 1:07:21I would say psychedelics can be supportive, but in the right time, in the right way,
- 1:07:26with the right person in the right context, and it's not gonna
- 1:07:30Fix everything for you overnight.
- 1:07:32Sure, right.
- 1:07:33W with the right frequency and and the right actions taken afterwards to
- 1:07:37to call it into our lives in the in the right ways.
- 1:07:41Um Okay, let's take a little pause from this episode.
- 1:07:44I'd like to send a big thanks to my patrons on Patreon who
- 1:07:48make this podcast possible.
- 1:07:50Yes, periodically there are sponsors to these episodes,
- 1:07:53but the reality is that the bulk of my capacity to invest time and money,
- 1:07:58resources into the production of this show is thanks to my patrons.
- 1:08:02An extra thanks goes to the people whose names are listed on the screen
- 1:08:05here on YouTube or in the description to this episode, wherever
- 1:08:08you're checking it out, as those individuals give quite significantly by month,
- 1:08:12some of Which for a very long time and their name and the credits
- 1:08:15is an extra thank you for that.
- 1:08:16If you listening are not yet a patron, I invite you to head to patreon.com
- 1:08:20forward slash James W Jesso uh to check it out.
- 1:08:23Link in the description.
- 1:08:25Like I said, this is my job.
- 1:08:26This is genuinely how I earn an income.
- 1:08:28Uh and I absolutely appreciate that all of
- 1:08:33us have an ongoing expectation that content online is free.
- 1:08:37And this podcast is free in the sense that you don't have to pay
- 1:08:41for it, but I have to pay for it.
- 1:08:43And I pay for it in time and I pay for it in finances.
- 1:08:45And if you find value in it, I would love to receive your contribution to the
- 1:08:51ongoing investments that I and others make to keep this podcast something
- 1:08:55I can give my, you know, the best hours of my day to.
- 1:08:59If instead of an ongoing Monthly pledge you'd like to just
- 1:09:01offer me a donation for a single episode, you can do so through PayPal or
- 1:09:05cryptocurrencies.
- 1:09:06I know that's still that is still a thing.
- 1:09:09Um and links to that are in the description to this episode.
- 1:09:13If you are not able to contribute financially to the show, that's all right.
- 1:09:17Thank you so much for listening.
- 1:09:18You can like, comment, subscribe, anything that engages the
- 1:09:22algorithm and sort of leaves a record somewhere that tells other
- 1:09:26people that you like the show and by default, you know, information.
- 1:09:30that they might like it too.
- 1:09:32That too would be incredibly helpful if financial support is not where you're at.
- 1:09:36So that's it for this little Patreon break.
- 1:09:39Thank you again so much to my patrons and thank you in advance to my
- 1:09:42upcoming future patrons and people leaving donations.
- 1:09:46And now let's get back into this interview with Shelby Hartman,
- 1:09:49here on Adventures Through the Mind.
- 1:09:52No, I know uh I know I just uh I
- 1:09:56just a few minutes ago was like my goal with the podcast is
- 1:10:00Just to not try to not get myself swept up in the next algorithmic wave of the
- 1:10:05next this or that.
- 1:10:07Um And yet those waves are still happening.
- 1:10:12And I've noticed that they there's
- 1:10:15been a bit of a lull after an initial big wave, and I start to wonder to myself
- 1:10:22Um and I'm gonna ask this question to you.
- 1:10:26Do you think that th what we're seeing right now is this so called psychedelic
- 1:10:31renaissance is a kind of psychedelic revolution?
- 1:10:35in terms of like what will be at least an allowable part of existing
- 1:10:41legally in society, um, if not something much more dramatic.
- 1:10:46Uh or do you think that this is gonna end up being a short lived
- 1:10:52Media fad In some way or another.
- 1:10:55And and why or why not?
- 1:10:58Yeah, I mean psychedelics are not going anywhere, um,
- 1:11:02because they've been with humanity since the beginning of time.
- 1:11:06The question is what will that look like?
- 1:11:11Will they be integrated into
- 1:11:15the systems and society that we have now.
- 1:11:19Well, we don't even know if the systems and society we have now will
- 1:11:22be in existence in ten or fifteen or fifty or a hundred years.
- 1:11:26So I have no idea.
- 1:11:28Um but I but but the plants and the fungi themselves are not going anywhere.
- 1:11:34Um they are uh there will always be people So long as there are people,
- 1:11:39and maybe even after there are people, if there's ever such a time.
- 1:11:44That will be quietly And sacredly.
- 1:11:49Preserving.
- 1:11:50these medicines and the knowledge around them.
- 1:11:56And not everybody, not every medicine.
- 1:11:59wants to be found and wants to be proliferated in the mainstream
- 1:12:02and let's keep it that way.
- 1:12:08Is that something you do this is a side question I hadn't thought,
- 1:12:12like is this something that Because you're on the you're on the cutting edge.
- 1:12:17I know I know what it is 'cause I'm you know, I'm I'm I I'm at a
- 1:12:19different level of maybe success
- 1:12:23depending on how you define that in in comparison to double
- 1:12:26the excuse me, DoubleBlind.
- 1:12:28But I know that I have the inside scoop on a lot of things.
- 1:12:32And there are certain things that I actively don't r bring
- 1:12:35up on the podcast because I'm conscientious about how they're gonna be received or
- 1:12:40the impact they might have.
- 1:12:41There was a while there where I wouldn't mention three MMC on the podcast because I
- 1:12:46didn't want it to get popular because it was still this
- 1:12:49avenue for some deep incredible healing work and then all of a
- 1:12:52sudden it exploded and everyone's trying to get it and there's you know
- 1:12:55actions being taken against this purchase and so on and so forth.
- 1:12:58Do you Are you in in DoubleBlind, are you being protective?
- 1:13:04I know I'm not talking about stuff that's protecting people's safety and security.
- 1:13:06I mean in the sense of certain knowledge.
- 1:13:08Are you being protective not to popularize things?
- 1:13:11Um for that same reason that maybe something shouldn't be known by the world.
- 1:13:19Well
- 1:13:25It's a tricky question.
- 1:13:28I would say
- 1:13:37You know, I would say that I am in
- 1:13:40dialogue with myself all the time, as I think is probably every journalist that uh
- 1:13:46seeks to to be in integrity and do good work um around
- 1:13:51what to talk about and what to not talk about.
- 1:13:55Right.
- 1:13:55And that gets into some very deep ethical questions around the function of of
- 1:14:01journalism and education in our culture.
- 1:14:05Um 'Cause some people might say, Well, journalism is just supposed to
- 1:14:10report on whatever is happening.
- 1:14:13You know, I have been a journalist since I was nineteen and I'm thirty-six now.
- 1:14:18I was a working journalist before I graduated college.
- 1:14:21So I've been at it for a long time and I majored in philosophy too.
- 1:14:24So I'm very interested in ethics and I've been sitting with these
- 1:14:27questions for a long time.
- 1:14:30And I just I don't necessarily believe in sort of the gold standard, you know
- 1:14:36illusion of objectivity and this idea that journalists just can completely divorce
- 1:14:42themselves and that they just have to report on whatever it is that
- 1:14:45they see exactly as they see it.
- 1:14:48I mean I think journalism, you know, it's it's really intended to
- 1:14:53promote compassionate and critical social discourse and to um
- 1:15:00you know, hopefully move society to a to a kinder
- 1:15:05uh and more equitable place.
- 1:15:07And so what I decide to talk about, not talk about, is all in service of that
- 1:15:13mission.
- 1:15:14And if, you know, um, if someone is doing good work quietly, supporting people
- 1:15:20and healing them.
- 1:15:22you know, um, and putting their lives on the line to do that.
- 1:15:27No, I have I see no reason to to write about that person.
- 1:15:30Why wh why would I why would I do that?
- 1:15:32That doesn't serve anybody.
- 1:15:34To do that.
- 1:15:35Um But I do try and, you know, and this is a really big part of
- 1:15:41what the book tries to do, we do try to uh Demystify.
- 1:15:48parts of the psychedelic experience or journey, um, and world that are
- 1:15:54not talked about explicitly otherwise.
- 1:15:57Um We might talk, for example, about there's this is a big a big topic now.
- 1:16:03Even Maps did a panel on it, but in the early days we were
- 1:16:06talking about psychedelics and sex.
- 1:16:08We were talking about whether you should trip solo.
- 1:16:11We were talking about um
- 1:16:15Really like the nuts and bolts of what a lot of of ayahuasca ceremonies feel
- 1:16:20like, because that's information that you don't get even from the facilitator.
- 1:16:23You show up and you're kind of like, what's going on here?
- 1:16:26Yeah.
- 1:16:27I'm sitting where?
- 1:16:28We're doing what?
- 1:16:28We're drinking how much?
- 1:16:29What's it gonna feel like?
- 1:16:31My nose beforehand.
- 1:16:32Exactly. Yeah. What is this?
- 1:16:34This is this is tobacco.
- 1:16:36Where does it come from?
- 1:16:37What's it supposed to do?
- 1:16:38So there's a lot of information that people are not.
- 1:16:42still to this day not being given even by Integrist facilitators and a lot
- 1:16:46of questions that they have that are not being answered.
- 1:16:49And I think part of that is that um
- 1:16:54you know, there's a fear of the repeat of the sixties and seventies,
- 1:16:57and there's a lot of folks who are trying to legitimize psychedelics.
- 1:17:01who who just won't talk about things that ha aren't considered
- 1:17:04sort of institutional knowledge.
- 1:17:06So if you ask, you know, for example, a researcher at a university
- 1:17:12you know, hey, my wife just gave birth and she's stru
- 1:17:16struggling with suicidal ideation and she's dealing with postpartum
- 1:17:20depression and she wants to microdose, is that safe?
- 1:17:24You know.
- 1:17:25They're gonna say, Well, I can't talk about that because there's been no
- 1:17:29research with, you know, mushrooms and pregnant people.
- 1:17:34Cool.
- 1:17:35Now what does the wife do?
- 1:17:41So we don't talk about things we don't know about, but we do give the information to
- 1:17:45people that does exist with all the disclaimers we need to give.
- 1:17:49Which is like there's been some anecdotal research.
- 1:17:51This is what indigenous people do.
- 1:17:55You know?
- 1:17:57That's a really extreme example I gave, by the way, and the disclaimer being I'm not
- 1:18:00making any statements about whether someone should or should not
- 1:18:03microdose with postpartum depression, but Mikaela Delamico has done some
- 1:18:06really amazing studies on that and you should check him out if you're interested.
- 1:18:10Wonderful.
- 1:18:11Um yeah, I like I like I like what you're saying there
- 1:18:14too, 'cause I mean just to reference back to my own podcast here, it's
- 1:18:17like uh I I report on I'll do episodes on scientific s research and people who
- 1:18:22write books and yada yada.
- 1:18:24But then I also think to myself, like, Well, what are some of the
- 1:18:27conversations that aren't hap h happening?
- 1:18:30Can we how come we're not talking enough about the living
- 1:18:34intelligence of plants and uh you know, what's what are
- 1:18:37conversations that we could have about like ayahuasca as a um
- 1:18:42as uh something that can sort of uh well I recently interviewed a
- 1:18:46woman named uh Samantha Retrosi.
- 1:18:48We talked about ayahuasca as uh something that can break or
- 1:18:52sort of break down the oh, what'd she call it, like the academic
- 1:18:56industrial western mindset or something and like open us up to
- 1:19:00Like new ways to see the world and stuff like this.
- 1:19:03Oh yeah. Michael Pollan talks about that in his book as well.
- 1:19:07He's like just give a materialist ayahuasca.
- 1:19:10If you want them to start believing in God.
- 1:19:13Sure. Maybe maybe if you really want them to believe in God,
- 1:19:16you give them five M E O D M T.
- 1:19:18Um
- 1:19:22Let's round off the interview with this last question here.
- 1:19:24You know, you've referenced it a couple of times now your book.
- 1:19:27Um, and you know, you've talked about, you know, your ph p p philosophy,
- 1:19:31your integrity, your, you know, your your path as a journalist,
- 1:19:35what you choose to include and not include, and how you want what you choose to
- 1:19:39include and not include, and how you write about it to serve people.
- 1:19:43Um and one of the ways that you do this is through Drop a Blind,
- 1:19:47and another way that you've done it is through uh correct me, but I'm pretty
- 1:19:51sure it's called DoubleBlind's Guide to Psychedelics, which
- 1:19:55is not only Yeah, not only a book that has great information in it, but
- 1:20:00And I must not only credit, but like celebrate the fact that you decided as a
- 1:20:05part of this book to make it something that didn't just represent
- 1:20:09psychedelics and words, but kind of represented a whole sort of
- 1:20:14piece of what it is to like exist in psychedelic culture
- 1:20:17through its the visual medium.
- 1:20:19of the art that you included in the design, like the actual
- 1:20:23design and layout of the book and I just it's an absolutely gorgeous book.
- 1:20:28Um
- 1:20:31What um
- 1:20:35Tell us a little bit about this book.
- 1:20:37Um and What kind of impact you were hoping it was gonna have on the world
- 1:20:42and and who you were hoping it was gonna have that impact on.
- 1:20:47Mm-hmm.
- 1:20:48Well So the DoubleBlind Guide to Psychedelics is essentially
- 1:20:53it's a coffee table book, and it um includes
- 1:20:59information on how to prepare for and navigate and integrate
- 1:21:05experiences on the major psychedelics, which include ayahuasca,
- 1:21:09DMT, ketamine, mushrooms,
- 1:21:12LSD, and MDMA, I believe those are all of them.
- 1:21:16And there's another psychedelics chapter, too, which gives aLittle
- 1:21:19bit of information on lesser known psychedelics like two C B and um
- 1:21:24mescalin containing cacti.
- 1:21:26Um, but uh so You know, it's really for people.
- 1:21:31So the so that those parts of it, um, which is the bulk of the writing,
- 1:21:35are really for people that um want to go more deeply into
- 1:21:39psychedelic experience or who have never had a psychedelic experience and
- 1:21:44want kind of the most up-to-date information on how to do that.
- 1:21:48Um, but interspersed with what we sort of are referring to
- 1:21:51as interstitials, which is essentially reporting and storytelling on the culture,
- 1:21:57the ethics, indigenous reciprocity.
- 1:21:59Because for us, you know, there are some amazing books out there by longtime
- 1:22:05um psychedelic advocates that are giving people information on,
- 1:22:09you know, how to trip, for example, the difference between a
- 1:22:12microdose and a macrodose, but none that we've seen that are situating
- 1:22:17them within the cultural, political, and ethical framework of plant medicines.
- 1:22:22And as we've been talking about this whole conversation, you know,
- 1:22:26we do feel at DoubleBlind like anyone who is Engaging with these plants and fungi
- 1:22:31has a responsibility to consider their positionality within this current moment, uh,
- 1:22:36this current psychedelic moment.
- 1:22:39And that involves thinking about and understanding the origins of
- 1:22:44these medicines, how to give back to their stewards,
- 1:22:46how you can be involved in a local decriminalization effort if that's
- 1:22:49something that you want to do.
- 1:22:52And also just like, you know, fun quirky facts about how
- 1:22:56psychedelics are used in the underground for fun, for recognition.
- 1:22:59Creation, for joy, for dance, for embodiment, for all the things, right?
- 1:23:03Um, and we just wanted it to be something beautiful that people love
- 1:23:07to keep on their coffee tables.
- 1:23:09It just makes me so happy to go to random.
- 1:23:14Literally, I can't tell you how many times I've been invited to
- 1:23:17the house of someone and I don't even know them, and the magazine is just sitting
- 1:23:21on their coffee table.
- 1:23:22And so we wanted the book to be sort of a an even more elevated
- 1:23:26aesthetic experience, just a really beautiful art.
- 1:23:29object that people love to just keep around and flip through
- 1:23:32while they're tripping or not.
- 1:23:36Yeah, well it certi it certainly lands in that way.
- 1:23:38And and might I also say that, you know, you um in terms of this sort
- 1:23:42of like people need to consider their positionality on these things.
- 1:23:45I loved that all of that, as far as my read, was included as an as a as a
- 1:23:53um non imposing invitation to think
- 1:23:56about rather than uh you know sometimes Understandably so.
- 1:24:00Uh those types of considerations are more like demands than they are invitations.
- 1:24:05So I thought it was all woven together very, very nicely.
- 1:24:08Like I've told friends I know that this is a great book for a beginner,
- 1:24:12but also if you're a psychonaut, this is a fantastic book to have on your
- 1:24:15shelf or on your coffee table, because it's uh it's great to look at.
- 1:24:19Um with that said, we're at the very end here.
- 1:24:23So uh Shelby, thank you so much for the for the work that you're
- 1:24:26doing in the world and um for coming on the show today.
- 1:24:31How do people uh get a copy of DoubleBlind's Guide to
- 1:24:35Psychedelics for their personal use uh in you know on their coffee table
- 1:24:39or in preparing for their journey?
- 1:24:41And then how can they follow up more with what you're doing
- 1:24:43personally and with DoubleBlind?
- 1:24:46Thank you for asking.
- 1:24:47So um The best way to support DoubleBlind, if a person would like to do that,
- 1:24:54is to become a member.
- 1:24:56And our annual membership includes all kinds of things.
- 1:25:00It includes workshops and a whole library of classes on how to grow
- 1:25:04mushrooms and how to microdose and on and on. And also the book.
- 1:25:08So that's that's the best way to support us.
- 1:25:11You can go on our website, doubleblindmag.com and become a member, and you'll you'll
- 1:25:15get with that the book as well as a subscription to the print magazine.
- 1:25:18If you just want the book, it's Available like in all the places
- 1:25:21where books are available.
- 1:25:22It's on Amazon, don't love Amazon, but it is there.
- 1:25:25That was not my choice.
- 1:25:27Um it's also I think on Book Soup.
- 1:25:29It's in Barnes and Noble, it's it might be in your local bookstore if you want to go
- 1:25:34in and ask them for it.
- 1:25:35That's always good a good thing for us.
- 1:25:37It's I don't know.
- 1:25:38It's it's it's it's all over the place.
- 1:25:40You you'll find it.
- 1:25:42And if you want to uh uh you know follow my personal work, you can follow me
- 1:25:48on Instagram at Shelby and A N N
- 1:25:51N N E H A R T, and I report for other outlets uh features on
- 1:25:56psychedelics and not on psychedelics, and I post them there, so you
- 1:26:00can you can follow along.
- 1:26:02Great. Thank you so much for that, Shelby.
- 1:26:04I'll make sure the uh links to all of that are contained in the
- 1:26:06show notes to this uh episode.
- 1:26:08And um that's all.
- 1:26:10Thank you so much.
- 1:26:11Thank you.
- 1:26:13And cut.
- 1:26:14Okay, thanks for tuning into this episode of Adventures Through the Mind.
- 1:26:17I'll make sure all the links to uh you know get in contact or follow Shelby's
- 1:26:22work are in the show notes of this episode.
- 1:26:24And uh do go get yourself a copy of uh DoubleBlind's Guide to Psychedelics.
- 1:26:28It is gorgeous.
- 1:26:29It is honestly absolutely gorgeous and a lot of great information in there.
- 1:26:33Uh if you would like to follow me, though, online or follow any of
- 1:26:38the things that I do, you can head to any of the social media things
- 1:26:41linked in the description to this.
- 1:26:44And uh that is mostly mostly Instagram, to be honest,
- 1:26:47at this point, and a newsletter.
- 1:26:48So please follow me there and a Telegram.
- 1:26:50Um, but yeah, you can follow me in those places.
- 1:26:53I thank you for tuning in.
- 1:26:55If you want to support the show, as you heard in the middle there,
- 1:26:57Patreon is an excellent way to do it.
- 1:26:59You could also leave a one time donation through PayPal,
- 1:27:02or you can leave a review of this show wherever you listen to it.
- 1:27:06Reviews are very helpful.
- 1:27:07If you want to leave a comment, I do respond to them as best I can.
- 1:27:10At the very least, I read all of them, be them on Spotify.
- 1:27:13by uh YouTube or elsewhere.
- 1:27:15So please do leave me a comment if you have any questions or suggestions
- 1:27:19about this episode or the show in general.
- 1:27:22It's been my pleasure and my privilege to be your host of this episode
- 1:27:26and to be someone that you uh you know gave a couple of hours of listening time to.
- 1:27:31I do not take it for granted.
- 1:27:33Once again I've been your host, James W Jesso, and until the next episode.
- 1:27:37Take care.